Synonyms: WU04
Compound class:
Synthetic organic
Comment: WU-04 is a noncovalent (reversible) inhibitor of the SARS-CoV-2 main protease (Mpro; 3CLpro) [1]. In vitro nhibition of SARS-CoV and MERS-CoV main proteases is also demonstrated.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
The half life of WO-04 is dramaitcally extended (in human liver microsomes) in the presence of ritonavir (which inhibits its metabolism by CYP3A4) [1]. Pharmacokinetics support oral administration, particulary when administered in conjunction with ritonavir. |
Selectivity at other protein targets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|